Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 189.00
-4.50 (-2.33%)
Jun 25, 2026, 1:30 PM CST
Lotus Pharmaceutical Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Lotus Pharmaceutical stock has a consensus rating of "Buy" and an average price target of $367.00. The average 1-year stock price forecast is 94.18% higher than the current stock price, while the lowest is $200.00 (+5.82%) and the highest is $500.00 (+164.55%).
Price Target: $367.00 (+94.18%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Lotus Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 4 |
Financial Forecast
Revenue This Year
35.80B
from 20.51B
Increased by 74.57%
Revenue Next Year
40.95B
from 35.80B
Increased by 14.36%
EPS This Year
13.43
from 18.14
Decreased by -25.98%
EPS Next Year
23.37
from 13.43
Increased by 74.02%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 36.8B | ||
| Avg | 35.8B | ||
| Low | 34.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 79.6% | ||
| Avg | 74.6% | ||
| Low | 69.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 13.43 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -26.0% | ||
| Low | - |